• 5-Methyl-CTP for Smarter mRNA Design

  2026-08-27

  5-Methyl-CTP can help researchers tune transcript chemistry for enhanced mRNA stability and improved mRNA translation efficiency. This article connects modified nucleotide selection with the delivery and assay-design lessons of an outer membrane vesicle mRNA vaccine study.

• PHF2, Neuroinflammation, and Alzheimer’s Disease

  2026-08-27

  A 2025 Molecular Psychiatry study identifies the histone demethylase PHF2 as an epigenetic regulator linking inflammatory gene expression with synaptic and cognitive dysfunction in Alzheimer’s disease. By combining human, cellular, genomic, and 5xFAD mouse evidence, the work shows that Phf2 knockdown can reduce neuroinflammation and improve spatial memory, while also defining important limits for translation.

• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-08-26

  BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2 signaling, angiogenesis, and tumor-model biology. Its water insolubility and organic-solvent formulation mean it should not be used directly in aqueous workflows without solvent controls and formulation checks, and it is not a substitute for a broad-spectrum kinase inhibitor.

• Toremifene: A Mechanism-Led Prostate Cancer Assay Guide

  2026-08-26

  Toremifene is a second-generation selective estrogen-receptor modulator for investigating hormone-responsive cancer biology. This guide connects its concentration-controlled cell assays with the TSPAN18–STIM1 calcium-signaling study while distinguishing established evidence from testable research hypotheses.

• Catalpol Workflows for Translational Disease Models

  2026-08-25

  Catalpol, also known as Catalpinoside, supports a practical bridge from concentration-response assays to neuroprotection, bone, stroke, liver, and oncology models. This guide emphasizes dosing, pathway-aware controls, assay selection, and troubleshooting for more reproducible bench-to-animal workflows.

• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-08-25

  BFH772 is a selective VEGFR2 kinase inhibitor for controlled studies of VEGFR2-mediated angiogenesis, including tumor-model research. Its organic-solvent compatibility and water insolubility require careful formulation, vehicle controls, and precipitation checks; it is not appropriate for workflows requiring water-soluble or broad-spectrum kinase inhibition.

• Lovastatin Workflows for Mevalonate Research

  2026-08-24

  Lovastatin is a pathway-level probe for connecting HMG-CoA reductase inhibition with cholesterol metabolism, proliferation, apoptosis, and macrophage clearance. This practical guide translates its concentration- and time-dependent behavior into assay workflows while using a recent plant meristem study to illustrate rigorous temporal and orthogonal experimental design.

• Lovastatin for Reliable Cell Assays

  2026-08-24

  Learn how Lovastatin (SKU A4365) can be used to design, optimize, and interpret cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects mechanism, solvent handling, concentration selection, and supplier evaluation to documented quantitative data.

• Thymoquinone Limits Doxorubicin Cardiotoxicity

  2026-08-23

  A mouse study reports that Thymoquinone protects cardiac function during doxorubicin exposure and associates this effect with Nrf2/HO-1 signaling, improved redox status, and reduced ferroptosis-related injury. The findings provide a useful preclinical framework for studying cardioprotection while leaving pathway causality, pharmacokinetics, and preservation of doxorubicin antitumor activity unresolved.

• Biotin Azide for CuAAC Biotinylation

  2026-08-22

  Biotin Azide is a terminal-alkyne labeling reagent for copper-catalyzed click chemistry. Its covalently attached biotin supports streptavidin-based detection, affinity purification, and imaging of labeled biomolecules under appropriately optimized aqueous conditions.

• Triazole ALDH2 Activators for Myocardial Ischemia

  2026-08-22

  The reference study reports a triazole-based series of aldehyde dehydrogenase 2 activators designed with molecular simulation to improve both activity and water solubility. Lead compound Z17 produced record-setting ALDH2 activation in vitro and improved cardiac function and biochemical injury markers in a mouse ischemia–reperfusion model, supporting further preclinical development while leaving pharmacokinetic and clinical questions unresolved.

• SIRT1/2 Inhibitor IV: Ran Lactylation Workflows

  2026-08-21

  SIRT1/2 Inhibitor IV (cambinol) provides a cell-permeable pharmacologic perturbation for linking sirtuin activity with Ran lactylation, STAT3 transport, acetylation, and stress responses. This workflow-focused guide shows how to use it alongside lactate manipulation, OGD/R, p53, tubulin, and apoptosis readouts while controlling for dual-target and dose-related limitations.

• Developmental SSRI Exposure and Mu Opioid Signaling

  2026-08-20

  This dissertation identifies a selective motivational deficit after developmental SSRI exposure: mice work less for reward, while reward liking and Pavlovian learning remain comparatively preserved. Pharmacological antagonism or viral knockdown of mu opioid receptors in the nucleus accumbens attenuated the deficit, highlighting opioid–serotonin interactions as a mechanistic direction for depression research.

• Stattic: Practical STAT3 Inhibitor Workflows

  2026-08-20

  Stattic is a small-molecule STAT3 inhibitor for connecting pathway engagement with apoptosis, therapy resistance, and radiation response. This workflow uses validated HNSCC performance data and the microbiome–NF-κB–IL6–STAT3 findings from prostate cancer research to design stronger, better-controlled experiments.

• FCCP Workflows for Mitochondrial and HIF Studies

  2026-08-19

  FCCP enables controlled disruption of oxidative phosphorylation to connect oxygen consumption, ATP production, and hypoxia signaling in cell-based experiments. This guide translates that perturbation into reproducible workflows and shows how it can complement emerging research on mitochondria-derived pre-peroxisomes.

8676 records 1/579 page Next 12345 下5页 Last page